Kösters J P, Gøtzsche P C
Nordic Cochrane Centre, Rigshospitalet, Dept. 7112, Blegdamsvej 9, 2100 Copenhagen Ø, Denmark.
Cochrane Database Syst Rev. 2003;2003(2):CD003373. doi: 10.1002/14651858.CD003373.
Breast self-examination and clinical breast examination have been promoted for many years as general screening methods to diagnose breast cancer at an earlier stage in order to decrease morbidity and or mortality. The possible benefits and harms remain unclear.
To determine whether screening for breast cancer by regular self-examination or clinical breast examination reduces breast cancer mortality and morbidity.
The Cochrane Library and Medline were searched for randomised trials; date of last search October 2002. The specialised register maintained by the Cochrane Breast Cancer Group was searched.
Randomised clinical trials, including cluster randomised trials.
Decisions on which trials to include were taken independently by the reviewers based on the methods of trial. Disagreements were resolved by discussion. Intention to treat analyses were conducted using a fixed effect model with 95% confidence intervals.
Two large population-based studies (388,535 women) from Russia and Shanghai that compared breast self-examination with no intervention were included. There was no statistically significant difference in breast cancer mortality, relative risk 1.05 (95% confidence interval (CI) 0.90 to 1.24) (587 deaths in total). In Russia, more cancers were found in the breast self-examination group than in the control group (relative risk 1.24, 95% CI 1.09 to 1.41), while this was not the case in Shanghai (relative risk 0.97, 95% CI 0.88 to 1.06). Almost twice as many biopsies (3406) with benign results were performed in the screening group compared to the control group (1856), relative risk 1.89, 95% CI 1.79 to 2.00.
REVIEWER'S CONCLUSIONS: Data from two large trials do not suggest a beneficial effect of screening by breast self-examination whereas there is evidence for harms. There were no randomised trials of clinical breast examination. At present, breast self-examination cannot be recommended.
多年来,乳房自我检查和临床乳房检查一直作为一般筛查方法被推广,旨在早期诊断乳腺癌,以降低发病率和/或死亡率。其潜在的益处和危害仍不明确。
确定通过定期自我检查或临床乳房检查筛查乳腺癌是否能降低乳腺癌死亡率和发病率。
检索Cochrane图书馆和Medline以查找随机试验;最后检索日期为2002年10月。还检索了Cochrane乳腺癌小组维护的专业注册库。
随机临床试验,包括整群随机试验。
纳入试验的决定由评审人员根据试验方法独立做出。分歧通过讨论解决。采用固定效应模型进行意向性分析,并给出95%置信区间。
纳入了两项来自俄罗斯和上海的大型人群研究(共388,535名女性),这两项研究将乳房自我检查与不进行干预进行了比较。乳腺癌死亡率无统计学显著差异,相对风险为1.05(95%置信区间(CI)为0.90至1.24)(总计587例死亡)。在俄罗斯,乳房自我检查组发现的癌症比对照组多(相对风险为1.24,95%CI为1.09至1.41),而在上海情况并非如此(相对风险为0.97,95%CI为0.88至1.06)。与对照组(1856例)相比,筛查组进行的良性活检(3406例)几乎是其两倍,相对风险为1.89,95%CI为1.79至2.00。
两项大型试验的数据未表明乳房自我检查筛查有有益效果,而有证据表明存在危害。没有关于临床乳房检查的随机试验。目前,不推荐进行乳房自我检查。